Market Analysis and Manufacturing Technologies

The H1N1 Influenza A (2009) pandemic has affected more than 0. 4 million people in 180 countries across the globe. The alphabets H and N designate the proteins Hemagglutinin and Neuraminidase present on the surface area of the virus. The flu first began in Mexico in March 2009, then affected the U. S., after which it spread across the globe. The H1N1/09 virus has genetic elements originating from avian, swine, and human sources, making it far more fatal than the 1918 H1N1 (Spanish Flu) outbreak. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The H1N1 Vaccines market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analysed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

With the grand success of Vaccines Asia Pacific 2015 conference, Conference Series LLC is organizing the “5th Annual Congress on Influenza, Respiratory Diseases & Infections: Vaccines and Therapeutics (IRDI Vaccines 2016)” will be scheduled during December 01-02, 2016 at Atlanta, USA. IRDI Vaccines 2016 bring together the Global leaders in Immunology and relevant fields to present their research at this exclusive scientific program. IRDI Vaccines 2016 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions. 

  • Surveillance
  • Verification of the Vaccine Strain
  • Preparation of Reagents to Test the Vaccine (with reference reagents)
  • Optimization of Virus Growth Conditions
  • Vaccine Bulk Manufacture
  • Quality Control
  • Vaccine Filling and Release
  • Recent Techniques and Innovation

Related Conference of Market Analysis and Manufacturing Technologies

September 18-19, 2017

20th Global Summit & Expo on Vaccines, Immunization & B2B

(Global B2B Meetings in 1 Event) Houston, Texas USA
October 05-07, 2017

World Vaccines and Immunization Congress

Osaka, Japan
October 30-31, 2017

19th International Vaccines & B2B Congress

Chicago, USA
July 21-24 2016

Global marketing conference

Hong kong
Marc h 10-11 2016

Digital Marketing Innovation Summit

New York
February 23rd 2016

The vaccines Africa conference

Nairobi Kenya
May 13-17 2016

World s leading annual all-immunology event

January 10-14 2016

Metabolism Transcription and Disease J2

Utah USA
May 8-12 2016

Nucleic Acid Sensing Pathways Innate Immunity Immunobiology and Therapeutics E2

Dresden Germany
January 21-22 2016

Incidence Severity and Impact of Influenza

Paris France
February 7-11 2016

Stromal Cells in Immunity Q4

Keystone Resort USA
December 4-8 2016

Cellular Stress Responses and Infectious Agents S4

New Mexico USA
July 25-26 2016

Stromal Cells in Immunity Q4

Chicago USA

Market Analysis and Manufacturing Technologies Conference Speakers

Recommended Sessions

Related Journals

Are you interested in